HCW Biologics enters $3M in consulting agreements contingent on public offering closing

HCW Biologics Inc.

$2.5M marketing consulting deal with I.R. Agency for 12 days of news distribution campaigns over 60 days starting May 1, 2026.
$500K consulting agreement with Bowery Consulting for six-month term covering business strategy, capital raising, and market messaging.
Both agreements contingent on closing of a public offering via Form S-1 (filed Apr 23, amended Apr 24, 2026); fees paid from offering proceeds.
Marketing Consultant is not a registered broker/dealer, will not solicit investors, and makes no guarantee of trading volume or stock price.
Consultant fees are non-refundable under any circumstances, including termination or dissatisfaction.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.